Shenzhen Mindray Bio-Medical Electronics Future Growth
Future criteria checks 3/6
Shenzhen Mindray Bio-Medical Electronics is forecast to grow earnings and revenue by 15.1% and 15.2% per annum respectively. EPS is expected to grow by 17.7% per annum. Return on equity is forecast to be 34.8% in 3 years.
Key information
15.1%
Earnings growth rate
17.7%
EPS growth rate
Medical Equipment earnings growth | 22.5% |
Revenue growth rate | 15.2% |
Future return on equity | 34.8% |
Analyst coverage | Good |
Last updated | 16 Aug 2024 |
Recent future growth updates
Recent updates
Risks To Shareholder Returns Are Elevated At These Prices For Shenzhen Mindray Bio-Medical Electronics Co., Ltd. (SZSE:300760)
Aug 12Shareholders Would Enjoy A Repeat Of Shenzhen Mindray Bio-Medical Electronics' (SZSE:300760) Recent Growth In Returns
Jul 28Estimating The Fair Value Of Shenzhen Mindray Bio-Medical Electronics Co., Ltd. (SZSE:300760)
Jun 06These 4 Measures Indicate That Shenzhen Mindray Bio-Medical Electronics (SZSE:300760) Is Using Debt Safely
May 21Analysts Have Made A Financial Statement On Shenzhen Mindray Bio-Medical Electronics Co., Ltd.'s (SZSE:300760) First-Quarter Report
Apr 30Shenzhen Mindray Bio-Medical Electronics Co., Ltd.'s (SZSE:300760) Share Price Not Quite Adding Up
Apr 21Shenzhen Mindray Bio-Medical Electronics (SZSE:300760) Looks To Prolong Its Impressive Returns
Apr 02Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
12/31/2026 | 58,813 | 19,778 | 17,361 | 20,337 | 25 |
12/31/2025 | 49,789 | 16,646 | 15,140 | 17,473 | 27 |
12/31/2024 | 41,740 | 13,925 | 11,344 | 14,492 | 27 |
3/31/2024 | 35,940 | 12,171 | 10,028 | 12,593 | N/A |
12/31/2023 | 34,932 | 11,582 | 8,373 | 11,062 | N/A |
9/30/2023 | 34,374 | 11,339 | 10,588 | 13,170 | N/A |
6/30/2023 | 33,486 | 10,762 | 10,460 | 12,547 | N/A |
3/31/2023 | 31,787 | 10,073 | 10,509 | 12,605 | N/A |
1/1/2023 | 30,366 | 9,607 | 10,226 | 12,141 | N/A |
9/30/2022 | 29,174 | 9,441 | 7,951 | 9,643 | N/A |
6/30/2022 | 27,847 | 8,945 | 7,896 | 9,552 | N/A |
3/31/2022 | 26,432 | 8,392 | 7,291 | 8,758 | N/A |
1/1/2022 | 25,270 | 8,002 | 7,596 | 8,999 | N/A |
9/30/2021 | 24,354 | 7,957 | 7,648 | 8,977 | N/A |
6/30/2021 | 23,240 | 7,548 | 6,828 | 8,184 | N/A |
3/31/2021 | 22,066 | 7,059 | 7,277 | 8,561 | N/A |
12/31/2020 | 21,026 | 6,658 | 7,687 | 8,870 | N/A |
9/30/2020 | 20,240 | 6,373 | 6,315 | 7,428 | N/A |
6/30/2020 | 18,915 | 5,765 | 5,903 | 6,832 | N/A |
3/31/2020 | 17,391 | 4,988 | 4,866 | 5,675 | N/A |
12/31/2019 | 16,556 | 4,681 | 3,945 | 4,722 | N/A |
9/30/2019 | 15,853 | 4,494 | 4,087 | 4,867 | N/A |
6/30/2019 | 15,151 | 4,217 | 3,939 | 4,628 | N/A |
3/31/2019 | 14,423 | 3,918 | 3,425 | 4,069 | N/A |
12/31/2018 | 13,753 | 3,719 | 3,356 | 4,035 | N/A |
9/30/2018 | 13,109 | 3,492 | 2,933 | 3,508 | N/A |
12/31/2017 | 11,174 | 2,589 | N/A | 3,300 | N/A |
12/31/2016 | 9,032 | 1,600 | N/A | 3,040 | N/A |
12/31/2015 | 8,013 | 910 | N/A | 2,024 | N/A |
12/31/2014 | 7,836 | 1,360 | N/A | 1,741 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: 300760's forecast earnings growth (15.1% per year) is above the savings rate (2.9%).
Earnings vs Market: 300760's earnings (15.1% per year) are forecast to grow slower than the CN market (21.9% per year).
High Growth Earnings: 300760's earnings are forecast to grow, but not significantly.
Revenue vs Market: 300760's revenue (15.2% per year) is forecast to grow faster than the CN market (13.4% per year).
High Growth Revenue: 300760's revenue (15.2% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: 300760's Return on Equity is forecast to be high in 3 years time (34.8%)